Prepare to Win the Grant
Grants underlie most cancer research. Increased competition for fewer resources means the success rate for federal grant applications has dropped significantly. This drop is especially worrisome when we think about what it means for our younger investigators, who are trying to build a successful research career.
This virtual course is designed for new and young investigators preparing future grant submissions, including career development awards (i.e., K awards, K equivalents) and pilot/research grants (i.e., R03, R21, etc.) Offered without cost to members of SWOG and other National Clinical Trials Network groups.
Investigators will participate in bi-weekly sessions over a 6-week period, including didactic lectures on grantsmanship and biostatistics, peer review sessions, and tips on how to complete various grant sections. There will be direct verbal feedback from peer reviewers with expertise in various research fields and experience in successful grant-writing, as well as access to biostatistical support. Before starting the course, participants will need to provide the grant mechanism and grant deadline, as well as working title for their proposal.
Sessions will include:
- Introduction to grant writing
- Presentation of specific aims
- Discussion of research plan/Biostatistics
- Peer review of research strategy
- Discussion of career development plan/other grant sections
- Peer review of full grant

Katherine Crew, MD, MS
Submissions Due: May 1, 2021
Next course start: Summer 2021
The SWOG Grant Writing Workshop is led by SWOG Executive Officer Dr. Katherine Crew. Other participating faculty will be invited to participate based on applicant areas of interest and grant mechanisms.
Eligibility:
- Applicants must be faculty members at a SWOG institution OR at a member institution within the National Clinical Trials Network (NCTN).
- Clinical Instructor/Lecturer appointments are also eligible to apply.
- Applicants must be actively preparing a grant (CDA or Pilot/Research) for submission within 2021-22.